跳至主要内容
临床试验/CTRI/2012/05/002649
CTRI/2012/05/002649招募中3 期

Homoeopathic therapy for lower urinary tract symptoms in men with benign prostatic hyperplasia: A randomized multicentric clinical trial

Central Council for Research in Homoeopathy0 个研究点目标入组 252 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
252

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • ?Men aged between 50-80 years with sign and symptoms of Benign Hyperplasia of Prostate.
  • ?Presence of BPH symptoms with IPSS score > 7.
  • ?Written informed consent
  • ?Patients who can act in accordance with the protocol
  • ?Prostate Specific Antigen PSA level equal to or below 4 ng/mL (to rule out suspected cases of malignancy)
  • ?On ultrasonic examination prostate weight should be > 20g/20cc/20ml).

排除标准

  • ?Patients who are not adequately symptomatic (mild according to IPSS).
  • ?Patients with serious underlying medical condition (eg. Severe renal, hepatic disease etc.)
  • ?Do not give informed consent.
  • ?Complete retention of urine for more than 24 hours
  • ?Prostatic carcinoma
  • ?Patients interested for surgery during the next six months.
  • ?Other possible causes of the symptoms such as recurrent Urinary Tract Infection, neurogenic bladder, or urethral stricture.

研究者

发起方
Central Council for Research in Homoeopathy

相似试验